Experiences and Decision-Making for CFTR Modulators: A Qualitative Analysis
Clinical Trial
Offered by: ±·±ð³¾´Ç³Ü°ù²õÌý°ä³ó¾±±ô»å°ù±ð²Ô'²õ
Location: Delaware Valley
Trial Name
Experiences and Decision-Making for CFTR Modulators: A Qualitative Analysis
What is the trial about?
To explore the experience of patients and families in the CF Community related to highly effective CFTR modulator therapy (HEMT). These medications include: Ivacaftor (Kalydeco®), Tezacaftor/Ivacaftor (Symdeko®), and Elexacaftor/Tezacaftor/Ivacaftor (Trikafta®).
Who can participate?
Children/adolescents with CF (ages 12-17); Adults with CF (18 and older); and Caregivers (e.g., parents or guardians) of individuals with CF.
What is involved?
If you provide consent for your participation, we will ask you to participate in a 30-60 minute phone or telehealth interview about your feelings and experiences around highly effective CFTR modulator therapy (HEMT). HEMT therapy includes the medications: Ivacaftor (Kalydeco®), Tezacaftor/ivacaftor (Symdeko®), and Elexacaftor/Tezacaftor/Ivacaftor (Trikafta®). We are interested in hearing about your experience and perspective whether or not you take these medications.
We will also ask you to complete a background questionnaire, which includes personal questions related to you and your family.
Is a Clinical Trial Right for Your Child?
Learn more about clinical trials and get answers to questions you might have.
![Two researchers in a lab wearing coats and gloves, one looks into a microscope. Two researchers in a lab wearing coats and gloves, one looks into a microscope.](/content/experience-fragments/nemours/us/en/site/clinical-trial/clinical-trails/_jcr_content/root/two_panel_block_righ/col2/image.coreimg.jpeg/1686927063568/block-research-lab-microscope.jpeg)